Xeolas Pharmaceuticals Limited

Investment Amount: €1.07m
Industry: Pharmaceuticals
Reason for Investment: Growth capital

The Goodbody 2018 EIIS Fund has invested €1.07m in Xeolas Pharmaceuticals Limited (Xeolas).

Xeolas is an innovative pharmaceutical company focused on the development of niche, patient-friendly medicines. Located on the Dublin City University (DCU) campus, Xeolas have a state-of-the-art facility with fully integrated development and production capability.

The investment is to enable Xeolas to promote and scale up a new product, whilst marketing their established product. The total investment will also accelerate the existing R&D programmes for other products and accelerate US market launch for its new product offering.

Xeolas have a very experienced management team and board of directors, and the EIIS management team are very excited about this investment, as its our first venture into the pharmaceuticals sector.

Looking to grow your business?

Are you looking to finance the growth of your business?